NEM
53
-2
PNR
63
3
IRM
57
-2
HD
35
4
QRVO
31
2
NSC
42
2
KEY
53
2
APH
73
2
PHM
74
3
CPB
44
-5
ADSK
52
4
GM
77
2
UNP
52
2
CCI
38
2
PNC
52
3
MAC
54
3
BSX
71
2
SLB
41
2
CAH
40
-3
AME
59
2
NEM
53
-2
PNR
63
3
IRM
57
-2
HD
35
4
QRVO
31
2
NSC
42
2
KEY
53
2
APH
73
2
PHM
74
3
CPB
44
-5
ADSK
52
4
GM
77
2
UNP
52
2
CCI
38
2
PNC
52
3
MAC
54
3
BSX
71
2
SLB
41
2
CAH
40
-3
AME
59
2
Financhill
Back

ACADIA Pharmaceuticals Vs. Minerva Neurosciences Industry Stock Comparison

Sell
46

ACAD
ACADIA Pharmaceuticals

Last Price:
17.06
Seasonality Move:
17.25%
Sell
41

NERV
Minerva Neurosciences

Last Price:
2.41
Seasonality Move:
22.08%
Sell
46
ACADIA Pharmaceuticals (ACAD) is a Sell

Is ACADIA Pharmaceuticals a Buy, Sell or Hold?

  • The current ACADIA Pharmaceuticals [ACAD] share price is $17.05. The Score for ACAD is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • ACAD is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
41
Minerva Neurosciences (NERV) is a Sell

Is Minerva Neurosciences a Buy, Sell or Hold?

  • The current Minerva Neurosciences [NERV] share price is $2.37. The Score for NERV is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • NERV is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ACAD Stock Price Chart

What is ACADIA Pharmaceuticals's stock price today?

  • The ACADIA Pharmaceuticals share price today is $17.05
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ACAD is experiencing selling pressure, which indicates risk of future bearish movement.

NERV Stock Price Chart

What is Minerva Neurosciences's stock price today?

  • The Minerva Neurosciences share price today is $2.37
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NERV is experiencing selling pressure, which indicates risk of future bearish movement.

ACAD Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.63 Sell
Relative Strength Index (14 RSI): 41.02 Sell
Chaikin Money Flow: -1076205 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (16.72 - 17.88) Sell
Bollinger Bands (100): (18.5 - 28.42) Sell

NERV Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.2 Sell
Relative Strength Index (14 RSI): 33.51 Sell
Chaikin Money Flow: -9275 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.41 - 2.53) Sell
Bollinger Bands (100): (2.47 - 8.05) Sell

ACAD Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 16.82 Buy
20-day SMA: 17.08 Sell
50-day SMA: 19.28 Sell
200-day SMA: 24.15 Sell
8-day EMA: 16.95 Buy
20-day EMA: 17.28 Sell
50-day EMA: 19.18 Sell
200-day EMA: 22.47 Sell

NERV Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.41 Sell
20-day SMA: 2.46 Sell
50-day SMA: 2.74 Sell
200-day SMA: 6.16 Sell
8-day EMA: 2.4 Sell
20-day EMA: 2.51 Sell
50-day EMA: 3.32 Sell
200-day EMA: 5.23 Sell

ACADIA Pharmaceuticals Earnings Growth & ACAD Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.64 per share, an increase next quarter of $0.07 per share, an increase this year of $0.99 per share, and an increase next year of $0.60 per share.

Minerva Neurosciences Earnings Growth & NERV Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.17 per share, an increase this year of $2.49 per share, and a decrease next year of $1.83 per share.

ACADIA Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Minerva Neurosciences Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):